GPI Pulse - Global Pricing Innovations Indication-Level Treatment Costs - Pharma Data

GPI pulse™ is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. This powerful platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access strategy, but can also be leveraged to rapidly extract customised sets of analysis-ready data. In addition to the drug-level price and reimbursement data, GPI pulse™ also offers indication-level treatment costs for a more granular view. This additional layer allows for standardised comparison of cost to treat a patient (per day/moth/annum) across markets and by specific indication. This indication-level data requires further calculations that consider the posology. For this reason, regulatory label approval data are incorporated to provide an accurate picture of the treatment costs per patient in each market. Use cases: - Understand the difference in cost to treat a patient by indication in a particular market - Compare the cost to treat a patient in different markets of interest - Standardised comparisons of the cost to treat a patient with different therapies - Visualise historical price evolution GPI continually invest in technology, taxonomy, and quality assurance, to ensure our data is the gold-standard in terms of accuracy, granularity, and timeliness. GPI pulse™ supports the full spectrum of biopharma clients, from top tier pharma to clinical stage biotech. The analytics tools within GPI pulse™ are built specifically with pricing, market access, and commercial strategy teams in mind. FREE DATA SAMPLES AVAILABLE: - Pricing - Cost of Treatment - Reimbursement and HTA

搜集汇总

背景与挑战

背景概述

GPI pulse™是一个动态的价值、定价和市场准入分析平台，通过算法整合多数据流，提供全球药品定价、报销及适应症层面的治疗成本信息。该平台支持标准化比较不同市场和适应症的患者治疗成本，并专为定价、市场准入和商业策略团队设计，确保数据在准确性、颗粒度和及时性方面达到高标准。